Active, not recruitingPhase 1NCT02774421

Pilot Study of the Effect of Trastuzumab and GM-CSF on Children With Recurrent Ependymoma

Studying Ependymoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Colorado, Denver
Principal Investigator
Margaret Macy, MD
University of Colorado, Denver
Intervention
Trastuzumab after SubQ GM-CSF(drug)
Enrollment
33 enrolled
Eligibility
21 years · All sexes
Timeline
2017 – 2026

Study locations (1)

Collaborators

Children's Hospital Colorado

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02774421 on ClinicalTrials.gov

Other trials for Ependymoma

Additional recruiting or active studies for the same condition.

See all trials for Ependymoma →

← Back to all trials